Internal Server Error

Longevityy.ai - About the company

Longevityy.ai is a funded company, founded in 2026. It operates as a Developer of genetic health analysis reports using clinical research databases. The company has 543 active competitors, including 82 funded and 25 that have exited. Its top competitors include companies like MyHeritage, 23andMe and Helix.

Company Details

Developer of genetic health analysis reports using clinical research databases. This platform transforms raw genetic data into structured health reports by utilizing information from clinical databases. It provides insights into drug and gene interactions, screens for clinical variants, and generates personalized protocols for nutrition and supplements. Additionally, the service includes tools for tracking blood biomarkers and monitoring lifestyle metrics to support wellness management.
Key Metrics
Founded Year
2026
Stage
Funding Raised
Investors
Ranked
727th among 755 competitors
Similar Companies
Sign up to download Longevityy.ai's company profile

Longevityy.ai's funding and investors

Longevityy.ai is a funded company. Longevityy.ai has 1 institutional investor.

chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Longevityy.ai's Competitors and alternates

Top competitors of Longevityy.ai include MyHeritage, 23andMe and Helix. Here is the list of Top 10 competitors of Longevityy.ai, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for MyHeritage
MyHeritage
2003, Yehud (Israel), Acquired
Provider of tools for creating family trees and exploring ancestry
$49M
77/100
2nd
Logo for 23andMe
23andMe
2006, Sunnyvale (United States), Acquired
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
$944M
77/100
3rd
Logo for Helix
Helix
2015, San Francisco (United States), Series E
Provider of a genomic database for clinical research
$435M
71/100
4th
Logo for Color
Color
2013, Burlingame (United States), Series E
Provider of end-to-end Virtual clinic offering cancer-based solutions
$491M
66/100
5th
Logo for Nucleus Genomics
Nucleus Genomics
2021, Manhattan (United States), Series A
Provider of genetic testing kits for rare variant analysis
$32M
62/100
6th
Logo for MyOme
MyOme
2017, San Carlos (United States), Series B
Provider of a platform for gene analysis to determine genetic diseases and drug response
$36M
61/100
7th
Logo for GenePlanet
GenePlanet
2008, Ljubljana (Slovenia), Series B
Genetics-based health and fitness recommendations
$34M
60/100
8th
Logo for Dante Labs
Dante Labs
2016, New York City (United States), Seed
Provider of whole-genome sequencing analysis for health and wellness
-
60/100
9th
Logo for Genomind
Genomind
2009, King Of Prussia (United States), Series C
Developer of genetic tests for personalised medicines to enhance mental health treatment
$64.4M
56/100
10th
Logo for Veritas Genetics
Veritas Genetics
2014, Danvers (United States), Acquired
Provider of genetic testing products
$53.4M
55/100
727th
Logo for Longevityy.ai
Longevityy.ai
2026, Funding Raised
Developer of genetic health analysis reports using clinical research databases
-
15/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Longevityy.ai's competitors? Click here to see the top ones

Longevityy.ai's Investments and acquisitions

Longevityy.ai has made no investments or acquisitions yet.

Reports related to Longevityy.ai

Here is the latest report on Longevityy.ai's sector:

FAQs about Longevityy.ai

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford